Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.

Kass, M A

Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial. [electronic resource] - Transactions of the American Ophthalmological Society 1989 - 598-618 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0065-9533


Adult
Aged
Demography
Double-Blind Method
Female
Glaucoma--physiopathology
Humans
Intraocular Pressure--drug effects
Longitudinal Studies
Male
Middle Aged
Ocular Hypertension--drug therapy
Optic Disk--physiopathology
Timolol--therapeutic use
Visual Fields--drug effects